電気泳動試薬の世界市場：ETBRダイ、SYBRダイ、ポリアクリルアミドゲル、デンプンゲル、アガロースゲル、TBEバッファー、TAEバッファー...市場調査レポートについてご紹介

1 Introduction (Page No. – 20)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Stakeholders

2 Research Methodology (Page No. – 23)
2.1 Research Data
2.1.1 Secondary Sources
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Sources
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Market Share Estimation
2.5 Assumption for the Study
2.6 Factor Analysis
2.6.1 Introduction
2.6.2 Demand-Side Analysis
2.6.2.1 Healthcare Expenditure Patterns
2.6.2.2 Rapid Growth of Aging Population
2.6.2.3 Incidence and Prevalence of Cancer
2.6.2.4 Burden of Infectious Diseases
2.6.2.5 Number of Clinical, Forensic, and Research Laboratories
2.6.3 Supply-Side Analysis
2.6.3.1 Number of New Product Launches: Electrophoresis Reagents vs Competitive Technologies
2.6.3.2 Parent Market Analysis: Electrophoresis Market

3 Executive Summary (Page No. – 41)

4 Premium Insights (Page No. – 47)
4.1 Market Overview
4.2 Market: Regional Mix
4.3 Geographical Snapshot of the Market
4.4 Asia-Pacific: Electrophoresis Reagents Market, By Product

5 Market Overview (Page No. – 51)
5.1 Introduction
5.2 Market Segmentation
5.3 Market Dynamics
5.3.1 Market Drivers
5.3.1.1 Rising Incidences of Cancer, Infectious Diseases, and Genetic Disorders
5.3.1.2 Increasing Funding for Genomic and Proteomic Research
5.3.1.3 Growing Number of Industry–Academic Research Collaborations
5.3.1.4 Rapidly Increasing Geriatric Population
5.3.1.5 Technological Advancements
5.3.2 Key Market Restraints
5.3.2.1 Time-Consuming Operations and Limited Sample Analysis Through Gel Electrophoresis
5.3.2.2 Presence of Alternative Technologies Offering Better Efficiency and Results
5.3.3 Key Market Opportunities
5.3.3.1 Rapid Growth in Emerging Countries
5.3.3.2 Increasing Demand for Personalized Medicine
5.3.3.3 Shift From Plant-Derived to Genome-Based Drug Discovery
5.3.4 Key Market Challenges
5.3.4.1 Safety Concerns Associated With Mutagenic Nucleic Acid Dyes

6 Industry Insights (Page No. – 61)
6.1 Introduction
6.2 Value Chain Analysis
6.3 Industry Trends
6.3.1 Increasing Adoption of Capillary Electrophoresis
6.3.2 Growing Consolidation of the Life Science Reagents Market
6.4 Stakeholder Analysis

7 Global Electrophoresis Reagents Market, By Product (Page No. – 66)
7.1 Introduction
7.1.1 Gels
7.1.1.1 Polyacrylamide Gels
7.1.1.2 Agarose Gels
7.1.1.3 Starch Gels
7.1.2 Dyes
7.1.2.1 Ethidium Bromide (ETBR) Dyes
7.1.2.2 Sybr Dyes
7.1.2.3 Other Dyes
7.1.3 Buffers

7.1.3.2 Tris-Acetate-Edta (TAE) Buffers
7.1.3.3 Other Buffers
7.1.4 Other Electrophoresis Reagents

8 Global Electrophoresis Reagents Market, By Technique (Page No. – 85)
8.1 Introduction
8.2 Gel Electrophoresis
8.3 Capillary Electrophoresis

9 Global Electrophoresis Reagents Market, By Application (Page No. – 90)
9.1 Introduction
9.2 Protein Analysis
9.3 DNA & RNA Analysis

10 Global Electrophoresis Reagents Market, By End User (Page No. – 95)
10.1 Introduction
10.2 Academic & Research Institutions
10.3 Pharmaceutical & Biotechnology Companies
10.4 Hospitals & Diagnostic Laboratories
10.5 Other End Users

11 Global Electrophoresis Reagents Market, By Region (Page No. – 103)
11.1 Introduction
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 France
11.3.3 U.K.
11.3.4 Italy
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Rest of Asia-Pacific
11.5 Rest of the World (RoW)
11.5.1 Latin America
11.5.2 Middle East and Africa

12 Competitive Landscape (Page No. – 175)
12.1 Overview
12.2 Market Share Analysis
12.3 Competitive Situations and Trends
12.3.1 Agreements, Partnerships, and Collaborations
12.3.2 Acquisition
12.3.3 New Product Launches
12.3.4 Expansion

13 Company Profiles (Page No. – 183)
13.1 Introduction
13.2 Thermo Fisher Scientific
13.3 Sigma-Aldrich Corporation
13.4 Bio-Rad Laboratories, Inc.
13.5 Qiagen N.V.
13.6 Merck Millipore
13.7 GE Healthcare
13.8 Agilent Technologies, Inc.
13.9 Lonza Group, AG
13.10 Takara Bio, Inc.
13.11 Harvard Bioscience, Inc.
13.12 Sebia Group

*Details on Financials, Products & Services, Key Strategy, & Recent Developments Might Not Be Captured in Case of Unlisted Companies.

14 Appendix (Page No. – 216)
14.1 Insights of Industry Experts
14.2 Discussion Guide
14.3 Additional Developments, 2012–2015
14.4 Introducing RT: Real-Time Market Intelligence
14.5 Related Reports